Details for 2010181323

Up to date per 03.04.2026

Actions

Title / Product Name

Antikörper gegen OPGL

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2010181323

EP Publication Number

2270052

E-Number

983340

Language

PCT Number

Publication Date

05.01.2011 A

28.03.2018 B1

Registration Date

28.03.2018

AT Publication Date

15.04.2018

Application Date

25.06.2002

Registration Number

Priorities

26.06.2001

301172 P

IPC

C07K 16/28 20060101AFI20180206BHEP

Maximum Duration of Protection

25.06.2022

Owner

Amgen Inc.One Amgen Center Drive Thousands Oaks, CA 91320US

Amgen Fremont Inc.One Amgen Center Drive Thousand Oaks, CA 91320US

Representative

Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT

Inventor

Boyle, William23629 Malibu Colony Drive Malibu, CA 90265US

Martin, Francis865 Fernhill Court Newbury Park, CA 91320US

Corvalan, Jose125 Williams Lane Foster City, CA 94404US

Davis, Geoffrey1132 Vancouver Avenue Burlingame, CA 94010US